The study falls within the scope of the HSMonitor project, a pre-commercial tender for the development of telematics solutions aimed at optimising patient health status and disease management. Specifically, the aim of this study is to test whether the adoption of HSMonitor solutions by healthcare professionals and patients improves the management of patients with high blood pressure.~This will be a randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions or to standard care.~The present pilot study is planned to be carried out within the framework of the EU project HSMonitor - Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimize hypertension care (Grant Agreement Nr. 856698).~The two solutions are referred to as:~Solution 1 - HSmartBPM (developed by a supplier consortium led by GNOMON)~Solution 2 - HyperHealth (developed by a supplier consortium led by TECH4CARE)
The goal of this clinical trial is to understand whether the adoption of digital solutions by healthcare professionals and patients improves the management of patients with high blood pressure.~The main questions it aims to answer are:~are these digital solutions feasible and well accepted by patients?~can these solutions, compared to standard care, allow a better hypertension control in patients with high blood pressure?~Participants randomised to one of the two intervention arms will be asked to adopt the digital solutions that include a smartphone app and 2 devices for blood pressure and body weight measurement that will be connected to the app.~Researchers will compare patients randomised in the two intervention groups with patients randomised to standard care (control group)